Geode Capital Management’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.1M | Buy |
689,926
+40,073
| +6% | +$818K | ﹤0.01% | 2142 |
|
2025
Q1 | $13M | Buy |
649,853
+21,657
| +3% | +$434K | ﹤0.01% | 2132 |
|
2024
Q4 | $16.7M | Buy |
628,196
+3,513
| +0.6% | +$93.6K | ﹤0.01% | 2062 |
|
2024
Q3 | $17.8M | Buy |
624,683
+7,004
| +1% | +$200K | ﹤0.01% | 2036 |
|
2024
Q2 | $13.4M | Buy |
617,679
+39,145
| +7% | +$852K | ﹤0.01% | 2148 |
|
2024
Q1 | $12.8M | Buy |
578,534
+12,419
| +2% | +$275K | ﹤0.01% | 2172 |
|
2023
Q4 | $12.2M | Buy |
566,115
+29,879
| +6% | +$645K | ﹤0.01% | 2223 |
|
2023
Q3 | $9.06M | Buy |
536,236
+38,552
| +8% | +$651K | ﹤0.01% | 2332 |
|
2023
Q2 | $6.83M | Buy |
497,684
+12,730
| +3% | +$175K | ﹤0.01% | 2525 |
|
2023
Q1 | $11M | Buy |
484,954
+19,287
| +4% | +$438K | ﹤0.01% | 2205 |
|
2022
Q4 | $11M | Buy |
465,667
+20,004
| +4% | +$471K | ﹤0.01% | 2205 |
|
2022
Q3 | $11.6M | Buy |
445,663
+15,107
| +4% | +$394K | ﹤0.01% | 2122 |
|
2022
Q2 | $9.45M | Buy |
430,556
+29,544
| +7% | +$648K | ﹤0.01% | 2290 |
|
2022
Q1 | $18M | Buy |
401,012
+15,271
| +4% | +$685K | ﹤0.01% | 1967 |
|
2021
Q4 | $16.5M | Buy |
385,741
+20,373
| +6% | +$873K | ﹤0.01% | 2087 |
|
2021
Q3 | $24.3M | Buy |
365,368
+25,293
| +7% | +$1.68M | ﹤0.01% | 1817 |
|
2021
Q2 | $24.9M | Buy |
340,075
+59,033
| +21% | +$4.33M | ﹤0.01% | 1817 |
|
2021
Q1 | $19.2M | Buy |
281,042
+48,005
| +21% | +$3.29M | ﹤0.01% | 1904 |
|
2020
Q4 | $15.6M | Buy |
233,037
+26,280
| +13% | +$1.76M | ﹤0.01% | 1876 |
|
2020
Q3 | $10.6M | Buy |
206,757
+94,912
| +85% | +$4.88M | ﹤0.01% | 1903 |
|
2020
Q2 | $4.22M | Buy |
111,845
+6,209
| +6% | +$234K | ﹤0.01% | 2432 |
|
2020
Q1 | $3.15M | Buy |
105,636
+46,901
| +80% | +$1.4M | ﹤0.01% | 2423 |
|
2019
Q4 | $2.02M | Buy |
58,735
+20,804
| +55% | +$715K | ﹤0.01% | 3004 |
|
2019
Q3 | $686K | Buy |
+37,931
| New | +$686K | ﹤0.01% | 3368 |
|